CYP2B6(C.516G>T)and CYP2A6(*9B and *17) polymorphisms are independent preictors of efavirenz plasma concentrations in HIV -infected patients,
dc.contributor.author | Kwara, A. | |
dc.contributor.author | Lartey, M. | |
dc.contributor.author | Rzek, N.L | |
dc.contributor.author | Court, M.H. | |
dc.date.accessioned | 2012-12-31T13:41:49Z | |
dc.date.accessioned | 2017-10-19T12:15:01Z | |
dc.date.available | 2012-12-31T13:41:49Z | |
dc.date.available | 2017-10-19T12:15:01Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | (67): 427-36 | en_US |
dc.identifier.uri | http://197.255.68.203/handle/123456789/2072 | |
dc.language.iso | en | en_US |
dc.publisher | Br. Journal Clin. Pharmacol (67): 427-36 | en_US |
dc.title | CYP2B6(C.516G>T)and CYP2A6(*9B and *17) polymorphisms are independent preictors of efavirenz plasma concentrations in HIV -infected patients, | en_US |
dc.type | Article | en_US |